share_log

愛帝宮:自願性公告關於附屬公司法定代表人變更及查閱財務會計報告事項

AIDIGONG: VOLUNTARY ANNOUNCEMENTREGARDING CHANGE IN LEGAL REPRESENTATIVE AND FINANCIAL REPORT REVIEW OF SUBSIDIARY

HKEX ·  Sep 20 07:00

Summary by Moomoo AI

愛帝宫(AIDIGONG)宣布,全資附屬公司廣東萬佳健康產業集團有限公司的股東會決議更換法定代表人,由朱昱霏女士變更為王愛兒女士,朱昱霏女士將繼續全職管理公司月子業務。此外,艾瑪資本提出委託第三方中介機構對深圳愛帝宮進行財務查閱,以了解其經營情況,該提案已獲全體股東同意。董事會認為此次變更及財務查閱將不會對集團業務經營產生影響。公告由愛帝宮主席王愛兒於2024年9月19日發布。
愛帝宫(AIDIGONG)宣布,全資附屬公司廣東萬佳健康產業集團有限公司的股東會決議更換法定代表人,由朱昱霏女士變更為王愛兒女士,朱昱霏女士將繼續全職管理公司月子業務。此外,艾瑪資本提出委託第三方中介機構對深圳愛帝宮進行財務查閱,以了解其經營情況,該提案已獲全體股東同意。董事會認為此次變更及財務查閱將不會對集團業務經營產生影響。公告由愛帝宮主席王愛兒於2024年9月19日發布。
Aidigong (AIDIGONG) announced that the shareholders' meeting of its wholly-owned subsidiary, Guangdong Wanjia Health Industry Group Co., Ltd., has decided to change the legal representative, from Ms. Zhu Yufei to Ms. Wang Aier. Ms. Zhu Yufei will continue to manage the company's postpartum business full-time. In addition, Emma Capital has proposed to commission a third-party intermediary institution to conduct a financial review of Shenzhen Aidigong to understand its operation. This proposal has been approved by all shareholders. The board of directors believes that this change and financial review will not have any impact on the group's business operation. The announcement was made by Chairman Wang Aier on September 19, 2024.
Aidigong (AIDIGONG) announced that the shareholders' meeting of its wholly-owned subsidiary, Guangdong Wanjia Health Industry Group Co., Ltd., has decided to change the legal representative, from Ms. Zhu Yufei to Ms. Wang Aier. Ms. Zhu Yufei will continue to manage the company's postpartum business full-time. In addition, Emma Capital has proposed to commission a third-party intermediary institution to conduct a financial review of Shenzhen Aidigong to understand its operation. This proposal has been approved by all shareholders. The board of directors believes that this change and financial review will not have any impact on the group's business operation. The announcement was made by Chairman Wang Aier on September 19, 2024.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more